A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma.

Respir Med Case Rep · 2021 · PMC8318922 · PMID 34336591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

reported that among patients who received platinum and pemetrexed combination in any setting, ALK-positive patients showed a trend towards longer PFS compared with the ALK-negative patients [ 22 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.